المؤلفون: Claire-Anne Siegrist, Bernard Fritzell, Hanspeter E. Gnehm, Ulrich Heininger, Christoph Aebi, Paul Balmer, Ray Borrow, Theodore F. Tsai, Bernard Vaudaux, Daniel Desgrandchamps, Ronald D. Pedersen

المصدر: Clinical and Vaccine Immunology, Vol. 13, No 8 (2006) pp. 854-61

مصطلحات موضوعية: Male, Microbiology (medical), Meningitis, Meningococcal/immunology/prevention & control, Time Factors, Vaccines, Conjugate/adverse effects/immunology/therapeutic use, Clinical Biochemistry, Immunology, Population, Meningococcal Vaccines, Meningococcal vaccine, ddc:616.07, Meningitis, Meningococcal, Immunoglobulin G, Microbiology, Antigen, medicine, Humans, Immunology and Allergy, Prospective Studies, education, education.field_of_study, ddc:618, Vaccines, Conjugate, biology, business.industry, Polysaccharides, Bacterial, Infant, Antibodies, Bacterial/blood, Vaccine Research, medicine.disease, Antibodies, Bacterial, Polysaccharides, Bacterial/immunology/pharmacology, Vaccination, Titer, Treatment Outcome, Immunoglobulin G/blood/immunology, biology.protein, Female, Antibody, business, Immunologic Memory, Meningitis, Switzerland, Meningococcal Vaccines/adverse effects/immunology/therapeutic use

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab91a1acfaba8a113f9ddbf49dafc3c
https://doi.org/10.1128/cvi.00059-06